Prof. Dr. Adriano Sabino is an Associate Professor at the Federal University of Minas Gerais. He is a Pharmacist who graduated from the Federal University of Ouro Preto with a Master's and Doctorate in Pharmaceutical Sciences from the Federal University of Minas Gerais and a Post-Doctorate from Michigan State University where he developed research into resistance to cancer therapy—Professor and Researcher in Clinical, Experimental and Molecular Hematology. He was a Leader of the onomatology research group developing research focusing on laboratory biomarkers and cancer therapy. He was a Member of the research groups: Oncohematology Research Center (leader), Nanomedicine Applied to Tumors, and Multifunctionalized Nanoparticles for Biological Application. He was an Advisor at the master's and doctoral levels of the postgraduate programs in Clinical and Toxicological Analysis, Bioinformatics, and Pharmaceutical Sciences, at UFMG. He served as Coordinator of the UFMG COVID-19 Diagnosis Support Committee (2020 -2021). His research focuses on continued investigations into cancer, leukemias, chemotherapy, biomarkers, genomics, proteomics and metabolomics, nanomaterials, regenerative medicine, cell therapy and bioinformatics.
Prof. Dr. Adriano Sabino is an Associate Professor at the Federal University of Minas Gerais. He is a Pharmacist who graduated from the Federal University of Ouro Preto with a Master's and Doctorate in Pharmaceutical Sciences from the Federal University of Minas Gerais and a Post-Doctorate from Michigan State University where he developed research into resistance to cancer therapy—Professor and Researcher in Clinical, Experimental and Molecular Hematology. He was a Leader of the onomatology research group developing research focusing on laboratory biomarkers and cancer therapy. He was a Member of the research groups: Oncohematology Research Center (leader), Nanomedicine Applied to Tumors, and Multifunctionalized Nanoparticles for Biological Application. He was an Advisor at the master's and doctoral levels of the postgraduate programs in Clinical and Toxicological Analysis, Bioinformatics, and Pharmaceutical Sciences, at UFMG. He served as Coordinator of the UFMG COVID-19 Diagnosis Support Committee (2020 -2021). His research focuses on continued investigations into cancer, leukemias, chemotherapy, biomarkers, genomics, proteomics and metabolomics, nanomaterials, regenerative medicine, cell therapy and bioinformatics.